Evaluation of novel radiotherapy technologies: what evidence is needed to assess their clinical and cost effectiveness, and how should we get it?
about
Which factors may determine the necessary and feasible type of effectiveness evidence? A mixed methods approach to develop an instrument to help coverage decision-makersThe cardiac dose-sparing benefits of deep inspiration breath-hold in left breast irradiation: a systematic reviewA critical review of recent developments in radiotherapy for non-small cell lung cancerPoint/Counterpoint. Future radiotherapy practice will be based on evidence from retrospective interrogation of linked clinical data sources rather than prospective randomized controlled clinical trials.Impact of treatment planning and delivery factors on gastrointestinal toxicity: an analysis of data from the RADAR prostate radiotherapy trial.Cost and effectiveness of image-guided radiotherapy for non-operated localized lung cancer: a population-based propensity score-matched analysisDoes a too risk-averse approach to the implementation of new radiotherapy technologies delay their clinical use?Evaluation of the utilization of external radiotherapy in the treatment of localized prostate cancer in Andalusia, Spain.Global radiation oncology waybill.Challenges of radiation oncology in Spain today.Proton beam therapy and localised prostate cancer: current status and controversiesTrans Tasman Radiation Oncology Group: Development of the Assessment of New Radiation Oncology Technology and Treatments (ANROTAT) Framework.Cost calculation: a necessary step towards widespread adoption of advanced radiotherapy technology.Mortality and cost of radiation therapy for oesophageal cancer according to hospital accreditation level: a nationwide population-based study.Intraoperative irradiation: precision medicine for quality cancer control promotion.Emerging trends in prostate cancer literature: medical progress or marketing hype?The future of predictive models in radiation oncology: from extensive data mining to reliable modeling of the results.Effect of patient choice and hospital competition on service configuration and technology adoption within cancer surgery: a national, population-based study.Hospital Quality Factors Influencing the Mobility of Patients for Radical Prostate Cancer Radiation Therapy: A National Population-Based Study.Access to innovative radiotherapy: how to make it happen from an economic perspective?Macroeconomic Policy Impact On Oncology-Related Public Expenditure In An Emerging European Market – Signs Of Early Recovery
P2860
Q26798243-9A8E3D11-B008-4534-BE15-16A704C02F72Q26801065-03C9A1DF-3621-4EA5-BE21-C9384169B0D3Q28079625-CA95107D-CCF0-479B-AE81-E2B68DF36556Q30769871-9BF56E51-F92F-4461-B1DC-C7EC4D02F080Q30877686-E3D0718D-CB41-46A9-9AAD-CFEDDB64E405Q36138377-96896558-A3D7-4B54-9DBB-3D09CD78FF87Q36235751-DA93FDBF-0A5B-4784-978B-5F42B4D5B935Q36416574-3C886871-5A5E-4BB3-816C-33FFA5C8A995Q37392311-46B3BAD7-8113-4BC3-BA1A-A46103750222Q37392449-CF2D4381-5F8A-4C44-9F01-BFFA20BAB360Q38088468-0F84232A-8651-4BF4-A05E-B8FEE05938EFQ38262810-622AE0F8-4DE5-4CD5-B073-0267AAFA767FQ38388288-4CFC24F5-7C65-4B9E-AF6D-38BC4742EA6EQ41495848-FAC4AE68-22D6-4750-8D3D-A573F9BD8FCEQ42324490-91AF91DB-D7A5-4CDF-AC12-0B1C21432980Q42696871-2D78A659-B74D-487F-B3D5-EA013457B276Q44073308-0AB60828-3280-40AA-A40D-34942C192CABQ47116489-4914AD52-E8E0-4E9F-8641-2FEBAF110BEEQ47166414-BA3398EA-8BA8-41B1-90B2-6226796019A3Q49069138-2D8D7165-9AB3-4EA6-A273-8A5C950D0359Q58440259-A3B0156A-0B63-4780-85E4-0BA0C8894DDA
P2860
Evaluation of novel radiotherapy technologies: what evidence is needed to assess their clinical and cost effectiveness, and how should we get it?
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Evaluation of novel radiothera ...... ess, and how should we get it?
@en
Evaluation of novel radiothera ...... ess, and how should we get it?
@nl
type
label
Evaluation of novel radiothera ...... ess, and how should we get it?
@en
Evaluation of novel radiothera ...... ess, and how should we get it?
@nl
prefLabel
Evaluation of novel radiothera ...... ess, and how should we get it?
@en
Evaluation of novel radiothera ...... ess, and how should we get it?
@nl
P2093
P1433
P1476
Evaluation of novel radiothera ...... ess, and how should we get it?
@en
P2093
Fergus Macbeth
Janneke Grutters
Judith van Loon
P304
P356
10.1016/S1470-2045(11)70379-5
P577
2012-03-30T00:00:00Z